Robert A. Medve

612 total citations
15 papers, 473 citations indexed

About

Robert A. Medve is a scholar working on Anesthesiology and Pain Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert A. Medve has authored 15 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Anesthesiology and Pain Medicine, 7 papers in Surgery and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert A. Medve's work include Anesthesia and Pain Management (6 papers), Anesthesia and Sedative Agents (6 papers) and Pediatric Pain Management Techniques (4 papers). Robert A. Medve is often cited by papers focused on Anesthesia and Pain Management (6 papers), Anesthesia and Sedative Agents (6 papers) and Pediatric Pain Management Techniques (4 papers). Robert A. Medve collaborates with scholars based in United States, Costa Rica and Israel. Robert A. Medve's co-authors include Lynn R. Webster, Rezaul Karim, Mark S. Schreiner, Julia C. Finkel, John B. Rose, Bruce P. Himelstein, Joel B. Gunter, Gregory J. Stoddard, Avital Cnaan and Charles J. Coté and has published in prestigious journals such as Clinical Cancer Research, Anesthesia & Analgesia and Drug and Alcohol Dependence.

In The Last Decade

Robert A. Medve

14 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Medve United States	12	219	147	130	103	97	15	473
Itic Zighelboim United States	12	126 0.6×	183 1.2×	70 0.5×	44 0.4×	102 1.1×	23	421
J. Brown United States	11	133 0.6×	122 0.8×	57 0.4×	25 0.2×	42 0.4×	16	293
Laurence Toms United Kingdom	5	190 0.9×	259 1.8×	43 0.3×	9 0.1×	58 0.6×	8	446
Brigitte Kuperwasser United States	6	265 1.2×	120 0.8×	34 0.3×	43 0.4×	210 2.2×	15	508
Sepideh Vahabi Iran	13	94 0.4×	189 1.3×	40 0.3×	14 0.1×	32 0.3×	41	355
Robinson Ep United States	9	66 0.3×	107 0.7×	38 0.3×	166 1.6×	10 0.1×	14	316
James Wild United States	9	287 1.3×	170 1.2×	77 0.6×	10 0.1×	187 1.9×	15	557
Ritu Lal United States	12	97 0.4×	90 0.6×	58 0.4×	42 0.4×	6 0.1×	19	429
Gill Mundin United Kingdom	8	125 0.6×	69 0.5×	40 0.3×	13 0.1×	117 1.2×	14	294
Warren Wen United States	14	194 0.9×	44 0.3×	30 0.2×	10 0.1×	202 2.1×	47	737

Countries citing papers authored by Robert A. Medve

Since Specialization

Citations

This map shows the geographic impact of Robert A. Medve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Medve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Medve more than expected).

Fields of papers citing papers by Robert A. Medve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Medve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Medve. The network helps show where Robert A. Medve may publish in the future.

Co-authorship network of co-authors of Robert A. Medve

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Medve. A scholar is included among the top collaborators of Robert A. Medve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Medve. Robert A. Medve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Medve, Robert A., et al.. (2022). Laser Shock Peening to Improve Performance of Metallic Ship Components. SNAME Maritime Convention.

Eldon, Michael A., Alan R. Kugler, Robert A. Medve, et al.. (2015). Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol. Clinical Pharmacology in Drug Development. 4(6). 442–448. 9 indexed citations

Eldon, Michael A., Alan R. Kugler, Robert A. Medve, et al.. (2015). Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending‐dose study. Clinical Pharmacology in Drug Development. 4(6). 434–441. 19 indexed citations

Webster, Lynn R., K.R. Gogas, Aleksandrs Odinecs, et al.. (2014). Abuse potential assessment of novel opioid analgesic NKTR-181: Implications for labeling and scheduling. Drug and Alcohol Dependence. 140. e239–e239. 1 indexed citations

Webster, Lynn R., et al.. (2012). Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral Oxycodone. Pain Medicine. 13(6). 790–801. 42 indexed citations

Jameson, Gayle, John Hamm, Glen J. Weiss, et al.. (2012). A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors. Clinical Cancer Research. 19(1). 268–278. 43 indexed citations

Vaughan, David, et al.. (2010). Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers. Clinical Therapeutics. 32(1). 146–160. 15 indexed citations

Gargano, Cynthia, Alice Jackson, Chan Beals, et al.. (2010). An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics. Advances in Therapy. 27(12). 963–980. 22 indexed citations

Webster, Lynn R., et al.. (2009). Opioid formulations in development designed to curtail abuse: who is the target?. Expert Opinion on Investigational Drugs. 18(3). 255–263. 52 indexed citations

10.

Rose, John B., et al.. (2003). Oral Tramadol for the Treatment of Pain of 7–30 Days’ Duration in Children. Anesthesia & Analgesia. 96(1). 78–81. 31 indexed citations

11.

Rose, John B., et al.. (2003). Oral Tramadol for the Treatment of Pain of 7–30 Days’ Duration in Children. Anesthesia & Analgesia. 96(1). 78–81. 32 indexed citations

12.

Finkel, Julia C., John B. Rose, Patrick K. Birmingham, et al.. (2002). An Evaluation of the Efficacy and Tolerability of Oral Tramadol Hydrochloride Tablets for the Treatment of Postsurgical Pain in Children. Anesthesia & Analgesia. 94(6). 1469–1473. 31 indexed citations

13.

Leeder, J. Steven, John T. Wilson, Andrea Gaedigk, et al.. (2002). Concordance between Tramadol and Dextromethorphan Parent/Metabolite Ratios: The Influence of CYP2D6 and Non‐CYP2D6 Pathways on Biotransformation. The Journal of Clinical Pharmacology. 42(1). 24–29. 46 indexed citations

14.

Finkel, Julia C., John B. Rose, Michael L. Schmitz, et al.. (2002). An Evaluation of the Efficacy and Tolerability of Oral Tramadol Hydrochloride Tablets for the Treatment of Postsurgical Pain in Children. Anesthesia & Analgesia. 94(6). 1469–1473. 49 indexed citations

15.

Medve, Robert A., et al.. (2001). Tramadol and acetaminophen tablets for dental pain.. PubMed. 48(3). 79–81. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact